US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
eFFECTOR Therapeutics Inc (EFTR)
eFFECTOR Therapeutics Inc (EFTR) ニュース

EFTR

eFFECTOR Therapeutics (EFTR)

eFFECTOR Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:EFTR

1 2 3 4 5 6 7 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/02/22	07 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EFTR	eFFECTOR Therapeutics Inc
2024/02/22	07 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EFTR	eFFECTOR Therapeutics Inc
2024/02/10	10 : 14	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:EFTR	eFFECTOR Therapeutics Inc
2024/01/30	22 : 31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EFTR	eFFECTOR Therapeutics Inc
2024/01/27	06 : 40	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EFTR	eFFECTOR Therapeutics Inc
2024/01/27	06 : 32	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:EFTR	eFFECTOR Therapeutics Inc
2024/01/10	22 : 06	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:EFTR	eFFECTOR Therapeutics Inc
2024/01/10	22 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EFTR	eFFECTOR Therapeutics Inc
2024/01/08	22 : 19	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:EFTR	eFFECTOR Therapeutics Inc
2024/01/08	22 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EFTR	eFFECTOR Therapeutics Inc
2023/12/08	22 : 31	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:EFTR	eFFECTOR Therapeutics Inc
2023/12/08	22 : 23	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EFTR	eFFECTOR Therapeutics Inc
2023/11/28	22 : 18	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:EFTR	eFFECTOR Therapeutics Inc
2023/11/28	22 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EFTR	eFFECTOR Therapeutics Inc
2023/11/14	06 : 25	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:EFTR	eFFECTOR Therapeutics Inc
2023/11/14	06 : 23	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EFTR	eFFECTOR Therapeutics Inc
2023/09/12	05 : 58	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:EFTR	eFFECTOR Therapeutics Inc
2023/09/12	05 : 51	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EFTR	eFFECTOR Therapeutics Inc
2023/08/09	05 : 36	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:EFTR	eFFECTOR Therapeutics Inc
2023/08/09	05 : 25	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:EFTR	eFFECTOR Therapeutics Inc
2023/08/09	05 : 11	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:EFTR	eFFECTOR Therapeutics Inc
2023/08/09	05 : 08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EFTR	eFFECTOR Therapeutics Inc
2023/08/05	05 : 06	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:EFTR	eFFECTOR Therapeutics Inc
2023/08/05	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EFTR	eFFECTOR Therapeutics Inc
2023/08/05	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EFTR	eFFECTOR Therapeutics Inc
2023/06/27	19 : 04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:EFTR	eFFECTOR Therapeutics Inc
2023/06/24	05 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:EFTR	eFFECTOR Therapeutics Inc
2023/06/08	19 : 15	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:EFTR	eFFECTOR Therapeutics Inc
2023/06/08	19 : 12	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:EFTR	eFFECTOR Therapeutics Inc
2023/06/08	19 : 07	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:EFTR	eFFECTOR Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:EFTR

1 2 3 4 5 6 7 次へ >>

Maire Tecnimont

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約